Deerfield Management Company, L.P. (Series C) Ideaya Biosciences, Inc. Transaction History
Deerfield Management Company, L.P. (Series C)
- $4.84 Billion
- Q1 2024
A detailed history of Deerfield Management Company, L.P. (Series C) transactions in Ideaya Biosciences, Inc. stock. As of the latest transaction made, Deerfield Management Company, L.P. (Series C) holds 2,630,292 shares of IDYA stock, worth $88.7 Million. This represents 2.38% of its overall portfolio holdings.
Number of Shares
2,630,292
Previous 2,630,292
-0.0%
Holding current value
$88.7 Million
Previous $93.6 Million
23.33%
% of portfolio
2.38%
Previous 2.3%
Shares
6 transactions
Others Institutions Holding IDYA
# of Institutions
206Shares Held
71.2MCall Options Held
29.8KPut Options Held
8.5K-
Black Rock Inc. New York, NY5.97MShares$201 Million0.01% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA4.86MShares$164 Million0.5% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.16MShares$140 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.05MShares$137 Million0.02% of portfolio
-
Janus Henderson Group PLC London, X03.81MShares$128 Million0.09% of portfolio
About IDEAYA Biosciences, Inc.
- Ticker IDYA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,067,700
- Market Cap $1.62B
- Description
- IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...